Anna Protopapas, Director: Mersana Therapeutics MRSN Sell · Filed 25/01/15

Trade details

Type: Insider sale
Amount: $7,612.44
Shares · price: 11,534 sh · $0.66 a share
Held after: 144,869 sh
Stock: Mersana Therapeutics MRSN
Person: Anna ProtopapasDirector
Trade date: 25/01/14
Filed: 25/01/15
Days to filing: 1 days

Sold 7.4% of holdings

Share of holding sold: 7.4%

Mersana Therapeutics trades, last 26 weeks

What else happened in Mersana Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/15~25/02/13

Anna Protopapas's recent trades

Anna ProtopapasDirector
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$5,009
8,637 sh
$5,009
Filed 25/01/17
Traded 25/01/16
Anna ProtopapasDirector
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$3,900
6,191 sh
$3,900
Filed 25/01/16
Traded 25/01/15
Anna ProtopapasDirector
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$79.7K
29,399 sh
$79.7K
Filed 24/01/17
Traded 24/01/16
Anna ProtopapasDirector
SellNuvalent
Sell
Nuvalent
NUVL
$378.4K
5,000 sh
$378.4K
Filed 23/12/20
Traded 23/12/18
Anna ProtopapasPresident & CEO
SellMersana Therapeutics
Sell
Mersana Therapeutics
MRSN
$99.6K
17,346 sh
$99.6K
Filed 23/01/18
Traded 23/01/17